Abstract
This study evaluated the quantity and quality of newly formed bone, stimulated by rhBMP-2 in combination with monoolein or chitosan gel as carriers, in critical bone defects created in 36 Wistar rat mandibles. Two weeks after surgery, the animals were anesthetized with 37.5% urethane submitted to perfusion and the hemi-mandibles removed for histological and histomorphometrical analysis. The results showed that there was a statistical difference between groups of animals receiving or not rhBMP-2 (p<0.05). Newly formed bone was more intense in the occlusal region, followed by the basal and middle regions, respectively. Both carriers, monoolein and chitosan gels were adequate for defect filling and control of protein release.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Bone Morphogenetic Protein 2
-
Bone Morphogenetic Proteins / administration & dosage
-
Bone Morphogenetic Proteins / pharmacology*
-
Bone Regeneration / drug effects*
-
Chitosan / pharmacology
-
Drug Carriers
-
Gels
-
Glycerides / pharmacology
-
Humans
-
Male
-
Mandible / drug effects*
-
Mandible / physiology
-
Rats
-
Rats, Wistar
-
Recombinant Proteins / pharmacology
-
Transforming Growth Factor beta / administration & dosage
-
Transforming Growth Factor beta / pharmacology*
Substances
-
BMP2 protein, human
-
Bmp2 protein, rat
-
Bone Morphogenetic Protein 2
-
Bone Morphogenetic Proteins
-
Drug Carriers
-
Gels
-
Glycerides
-
Recombinant Proteins
-
Transforming Growth Factor beta
-
Chitosan
-
monoolein